Trial Profile
Three Dimension Neuron Imaging Using 123I-metaiodobenzylguanidine Single Photon Emission Computed Tomography to Guide Ventricular Tachycardia Ablations
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2022
Price :
$35
*
At a glance
- Drugs Iobenguane (Primary)
- Indications Ventricular tachycardia
- Focus Diagnostic use
- Sponsors GE Healthcare
- 04 Apr 2018 Status changed from recruiting to completed.
- 23 Sep 2015 New trial record